DUSP5 and diabetes mellitus: Nevertheless, DUSP5 is a critical drug target for vascular-related diseases, and more broadly, MAPKs and their DUSP partners are involved in cell signaling that is directly involved in a wide range of diseases, including cancer, diabetes, and autoimmune disorders [6, 9–11].